Changchun BCHT Biotechnology Co. (SHA:688276)

Market Cap	7.43B -18.0%
Revenue (ttm)	624.69M -30.2%
Net Income	-241.11M
EPS	-0.59
Shares Out	413.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,555,303
Open	17.53
Previous Close	17.50
Day's Range	17.40 - 18.33
52-Week Range	13.30 - 24.47
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. It offers therapeutic biological products; general cargo road transport; special cargo transport and import and export of goods and technology. The company’s products Varicella vaccine, nasal spray flu vaccine, herpes zoster vaccine, liquid nasal spray flu vaccine. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,226
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688276

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error